LEAD FRAME FOR ASSEMBLING SEMICONDUCTOR DEVICE
    1.
    发明申请
    LEAD FRAME FOR ASSEMBLING SEMICONDUCTOR DEVICE 有权
    用于组装半导体器件的引线框架

    公开(公告)号:US20130234306A1

    公开(公告)日:2013-09-12

    申请号:US13605990

    申请日:2012-09-06

    IPC分类号: H01L23/495 H01L21/60

    摘要: A lead frame has a flag, a peripheral frame, and main tie bars coupling the flag to the peripheral frame. At least one cross tie bar extends between two of the main tie bars and an inner row of external connector pads extending from an inner side of the cross tie bar and an outer row of external connector pads extending from an outer side of the cross tie bar. Both an inner non-electrically conductive support bar and an outer non-electrically conductive support bar are attached across the two of the main tie bars. The inner non-electrically conductive support bar is attached to upper surfaces of the two of the main tie bars and to upper surfaces of the inner row of the external connector pads.

    摘要翻译: 引线框架具有标志,外围框架和将标志耦合到外围框架的主连接条。 至少一个交叉连接杆在两个主连接杆之间延伸,以及从交叉连接杆的内侧延伸的内排的外部连接器焊盘以及从交叉连接杆的外侧延伸的外部排的外部连接器焊盘 。 内部非导电支撑杆和外部非导电支撑杆都穿过两个主连接杆。 内部非导电支撑杆附接到两个主连杆的上表面和外部连接器垫的内排的上表面。

    Lead frame for assembling semiconductor device
    2.
    发明授权
    Lead frame for assembling semiconductor device 有权
    用于组装半导体器件的引线框架

    公开(公告)号:US08643156B2

    公开(公告)日:2014-02-04

    申请号:US13605990

    申请日:2012-09-06

    IPC分类号: H01L23/495 H01L21/60

    摘要: A lead frame has a flag, a peripheral frame, and main tie bars coupling the flag to the peripheral frame. At least one cross tie bar extends between two of the main tie bars and an inner row of external connector pads extending from an inner side of the cross tie bar and an outer row of external connector pads extending from an outer side of the cross tie bar. Both an inner non-electrically conductive support bar and an outer non-electrically conductive support bar are attached across the two of the main tie bars. The inner non-electrically conductive support bar is attached to upper surfaces of the two of the main tie bars and to upper surfaces of the inner row of the external connector pads.

    摘要翻译: 引线框架具有标志,外围框架和将标志耦合到外围框架的主连接条。 至少一个交叉连接杆在两个主连接杆之间延伸,以及从交叉连接杆的内侧延伸的内排的外部连接器焊盘以及从交叉连接杆的外侧延伸的外部排的外部连接器焊盘 。 内部非导电支撑杆和外部非导电支撑杆都穿过两个主连接杆。 内部非导电支撑杆附接到两个主连杆的上表面和外部连接器垫的内排的上表面。

    Method for producing ultra-clean gasoline
    3.
    发明授权
    Method for producing ultra-clean gasoline 有权
    超清洁汽油的生产方法

    公开(公告)号:US08597494B2

    公开(公告)日:2013-12-03

    申请号:US12726151

    申请日:2010-03-17

    IPC分类号: C10G51/06

    摘要: The present invention relates to a method for producing ultra-clean gasoline. The invention provides a method of hydro-upgrading inferior gasoline through deep desulfurization and octane number recovery, which comprises the following steps: cutting inferior full-range gasoline into the light and heavy fraction gasolines; contacting the light fraction gasoline successively with a catalyst for selective diene removal and a catalyst for desulfurization and hydrocarbon aromatization/single-branched-chain hydroisomerization; contacting the heavy fraction gasoline with a catalyst for selective hydrodesulfurization, and contacting the reaction effluent with a catalyst for supplemental desulfurization and hydrocarbon multi-branched-chain hydroisomerization; and blending the treated light and heavy fraction gasolines to obtain the ultra-clean gasoline product. The method of the invention is suitable for hydro-upgrading inferior gasoline, especially for hydro-upgrading inferior FCC gasoline with ultra-high sulfur content and high olefin content to obtain excellent hydro-upgrading effects.

    摘要翻译: 本发明涉及一种生产超清洁汽油的方法。 本发明提供了一种通过深度脱硫和辛烷值回收来升级劣质汽油的方法,包括以下步骤:将低级全程汽油切割成轻重汽油; 将轻馏分汽油依次与用于选择性二烯除去的催化剂和用于脱硫和烃芳构化/单支链加氢异构化的催化剂接触; 使重馏分汽油与催化剂接触以进行选择性加氢脱硫,并将反应流出物与用于补充脱硫和烃多支链加氢异构化的催化剂接触; 并混合经处理的轻质和重馏分汽油,得到超清洁汽油产品。 本发明的方法适用于升级劣质汽油,特别是用于加氢改造具有超高硫含量和高烯烃含量的劣质FCC汽油,以获得优异的水力升级效果。

    COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING LIPID LEVELS
    4.
    发明申请
    COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING LIPID LEVELS 有权
    化合物,组合物和减少脂质水平的方法

    公开(公告)号:US20120004223A1

    公开(公告)日:2012-01-05

    申请号:US13141310

    申请日:2009-12-22

    CPC分类号: C07D455/03 C07D495/04

    摘要: The present technology relates to compounds of Formulas (V) and (VI) and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.

    摘要翻译: 本技术涉及式(V)和(VI)的化合物及其制备和使用方法。 使用方法包括预防和治疗高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征。 本文公开的化合物还降低总胆固醇,低密度脂蛋白胆固醇和甘油三酸酯,并增加肝脏LDL受体表达,抑制PCSK9表达,并激活AMP激活的蛋白激酶。

    Compounds and compositions for reducing lipid levels
    7.
    发明授权
    Compounds and compositions for reducing lipid levels 有权
    用于降低脂质水平的化合物和组合物

    公开(公告)号:US08815900B2

    公开(公告)日:2014-08-26

    申请号:US13180144

    申请日:2011-07-11

    摘要: Compositions comprising extracts or isolated or purified compounds from plants of the genus Corydalis provide prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Corydalis compounds and their derivatives of natural and synthetic origins lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression and activate AMP-activated protein kinase. Specific stereoisomers of Corydalis compounds with lipid lowering activity include 14R-(+)-corypalmine, 14R,13S-(+)-corydaline, 14R-(+)-tetrahydropalmatin, (+)-corlumidin, d-(+)-bicuculline, and (+)-egenine.

    摘要翻译: 包含来自延胡索属植物的提取物或分离或纯化的化合物的组合物提供高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征的预防和治疗。 延胡索化合物及其天然和合成来源的衍生物降低总胆固醇,低密度脂蛋白胆固醇和甘油三酯,并增加肝脏LDL受体的表达并激活AMP激活的蛋白激酶。 具有降脂活性的延胡索化合物的具体立体异构体包括14R-(+) - 科帕胺,14R,13S-(+) - 番茄红素,14R-(+) - 四氢化合物,(+) - corlumidin,d - (+) - 和(+) - 依依。

    COMPOUNDS AND COMPOSITIONS FOR REDUCING LIPID LEVELS
    8.
    发明申请
    COMPOUNDS AND COMPOSITIONS FOR REDUCING LIPID LEVELS 有权
    用于减少脂质水平的化合物和组合物

    公开(公告)号:US20110269754A1

    公开(公告)日:2011-11-03

    申请号:US13180144

    申请日:2011-07-11

    摘要: Compositions comprising extracts or isolated or purified compounds from plants of the genus Corydalis provide prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Corydalis compounds and their derivatives of natural and synthetic origins lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression and activate AMP-activated protein kinase. Specific stereoisomers of Corydalis compounds with lipid lowering activity include 14R-(+)-corypalmine, 14R,13S-(+)-corydaline, 14R-(+)-tetrahydropalmatin, (+)-corlumidin, d-(+)-bicuculline, and (+)-egenine.

    摘要翻译: 包含来自延胡索属植物的提取物或分离或纯化的化合物的组合物提供高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征的预防和治疗。 延胡索化合物及其天然和合成来源的衍生物降低总胆固醇,低密度脂蛋白胆固醇和甘油三酯,并增加肝脏LDL受体的表达并激活AMP激活的蛋白激酶。 具有降脂活性的延胡索化合物的具体立体异构体包括14R-(+) - 科帕胺,14R,13S-(+) - 番茄红素,14R-(+) - 四氢化合物,(+) - corlumidin,d - (+) - 和(+) - 依依。

    Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same
    9.
    发明申请
    Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same 审中-公开
    用于调节脂质含量的化合物和组合物及其制备方法

    公开(公告)号:US20110009628A1

    公开(公告)日:2011-01-13

    申请号:US12832852

    申请日:2010-07-08

    摘要: The present technology relates to compounds of Formulas I-VI and methods of making and using such compounds. Methods of use include prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Compounds disclosed herein also increase HDL-C, lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression, inhibit PCSK9 expression, and activate AMP-activated protein kinase.

    摘要翻译: 本技术涉及式I-VI的化合物及其制备和使用方法。 使用方法包括预防和治疗高脂血症,高胆固醇血症,高甘油三酯血症,肝脂肪变性和代谢综合征。 本文公开的化合物还增加HDL-C,降低总胆固醇,低密度脂蛋白胆固醇和甘油三酸酯,并增加肝脏LDL受体表达,抑制PCSK9表达,并激活AMP激活的蛋白激酶。